Elsevier

Mitochondrion

Volume 36, September 2017, Pages 103-113
Mitochondrion

Mitochondrial dysfunction and oxidative stress in corneal disease

https://doi.org/10.1016/j.mito.2017.05.009Get rights and content

Abstract

The cornea is the anterior transparent surface and the main refracting structure of the eye. Mitochondrial dysfunction and oxidative stress are implicated in the pathogenesis of inherited (e.g. Kearns Sayre Syndrome) and acquired corneal diseases (e.g. keratoconus and Fuchs endothelial corneal dystrophy). Both antioxidants and reactive oxygen species are found in the healthy cornea. There is increasing evidence of imbalance in the oxidative balance and mitochondrial function in the cornea in disease states. The cornea is vulnerable to mitochondrial dysfunction and oxidative stress due to its highly exposed position to ultraviolet radiation and high oxygen tension. The corneal endothelium is vulnerable to accumulating mitochondrial DNA (mtDNA) damage due to the post- mitotic nature of endothelial cells, yet their mitochondrial genome is continually replicating and mtDNA mutations can develop and accumulate with age. The unique physiology of the cornea predisposes this structure to oxidative damage, and there is interplay between inherited and acquired mitochondrial dysfunction, oxidative damage and a number of corneal diseases. By targeting mitochondrial dysfunction in corneal disease, emerging treatments may prevent or reduce visual loss.

Introduction

The eye is a highly specialized organ of photoreception, an optical system able to focus the light energy from the environment on to the retina, which is the receptor of the visual pathway. The cornea, the anterior transparent window of the eye, is a crucial part of this optical system, creating 80% of the refractive power of the eye. The cornea is a dome-shaped transparent structure, and its shape and clarity, are the main characteristics enabling such great refractive power. The cornea, being avascular, obtains its nutrients from the tear film, the aqueous humour and blood vessels at the peripheral edge of the cornea. Human corneal transparency is the result of a number of related factors: avascularity, structural regularity of the covering epithelium, regular arrangement of the extracellular and cellular components in the stroma and functionality of the endothelium to regulate corneal hydration (Nita and Grzybowski, 2016, Zierhut et al., 2008). The normal corneal structure comprises of five well-defined layers from the external to internal corneal surface: the epithelium (multilayer), Bowman's layer, stroma (interlaced with keratocytes), the Descemet membrane and the endothelium (monolayer) (Fig. 1). Even small malfunctions or malformations in any of these components and/or an impaired communication between them can compromise their function. The unique physiology of the cornea predisposes this structure to oxidative damage, and there is interplay between inherited and acquired mitochondrial dysfunction, oxidative damage and a number of corneal diseases.

Mitochondrial mutations and dysfunction has been implicated in other ocular conditions. The most common mitochondrial disease is Leber's hereditary optic neuropathy (LHON) (Chinnery et al., 2001). This results in the degeneration of retinal ganglion cells and a progressive degeneration of the optic nerve (Jankauskaitė et al., 2016). About 70% of all LHON cases are caused by the 1178G > A mutation of the mitochondrial deoxyribonucleic acid (mtDNA) (Cwerman-Thibault et al., 2014). There is an increasing body of evidence from genetic studies that mtDNA mutations and subsequent dysfunction may contribute to the pathogenesis of other debilitating ocular conditions including glaucoma (Lascaratos et al., 2012, Sundaresan et al., 2014) and age related macular degeneration (AMD) (Terluk et al., 2015). Also rarely oncocytomas (or oncocytic adenomas) may arise in the simple or glandular epithelia of the ocular adnexa (Jones et al., 2016). In this condition these cells demonstrate an eosinophilic appearance and excessive and abnormal mitochondria content (Østergaard et al., 2011).

Section snippets

Mitochondrial function in the healthy cornea

Mitochondria have a functional genome separate from that of nuclear DNA (Leonard and Schapira, 2000). The human mitochondrial genome is 16,569 bp long and forms a closed circular molecule (Anderson et al., 1981). Human mitochondrial DNA contains 37 genes, all of which are essential for normal mitochondrial function. Thirteen of these genes encode enzymes, which are crucial for the oxidative phosphorylation pathway required for the production of the majority of cellular adenosine triphosphate

Oxidative stress and the cornea

The cornea, given its highly exposed position, receives a significant amount of high-tension atmospheric oxygen and sunlight, including the ultraviolet range. These factors result in the generation of ROS and subsequent oxidative stress in the cornea (Wenk et al., 2001). Oxidative stress in the cornea is a consequence of an imbalance between Reactive oxygen species (ROS) production and the antioxidant capacity of the corneal cells (Choi et al., 2011). Reactive nitrogen species (RNS), especially

Antioxidants and the cornea

In the healthy cornea antioxidants such as superoxide dismutase, catalase, ascorbate and glutathione are present (Chwa et al., 2006, Spector et al., 2002, Yamada et al., 1991). Ascorbate (vitamin C) acts as a reducing agent and reacts rapidly with ROS, such as superoxide anion and hydroxyl radical, thereby protecting the cornea from oxidative stress (Zierhut et al., 2008). Ascorbate acts as a filter from UV light, which is required for the prevention of light induced damage (Ringvold et al.,

Corneal endothelial dysfunction in inherited mitochondrial disease

Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of mitochondrial dysfunction caused by mutation of either nuclear DNA or mitochondrial DNA. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome (Chinnery, 2000). A corneal phenotype has been reported in Kearns-Sayre syndrome (KSS; MIM#530000) (Boonstra et al., 2002, Chang et al., 1994, Nakagawa et al., 1995, Ohkoshi et al., 1989

Mitochondrial dysfunction and oxidative stress in Fuchs endothelial corneal dystrophy

Fuchs endothelial corneal dystrophy (FECD) is a progressive, bilateral disease characterised by a gradual loss of corneal endothelial cells (CECs). Loss of CECs impairs the ability of the cornea to maintain hydration and results in a progressive decline in corneal transparency and hence a decline in vision (Bonanno, 2003, Elhalis et al., 2010). FECD is estimated to affect about 4% of the population, mostly in the fourth and fifth decade of life (Wojcik et al., 2013). In FECD there is an

Mitochondrial dysfunction and oxidative stress in keratoconus

Keratoconus is the leading cause of corneal transplantation in young people accounting for 25% of all transplants. Keratoconus affects around 1 in 2000 people in the United Kingdom. It is a lifelong condition, and is a significant health burden in work-age adults (Rabinowitz, 1998). The corneal thinning and protrusion due to keratoconus commences in teenage years with variable progression into mid-life, at which point it normally stabilises (see Fig. 4) (Rabinowitz, 1998). Clinically, the

Anti-oxidant and mitochondrial therapies for corneal disease

Corneal epithelial defects are commonly treated using agents known for their antioxidant properties e.g. ascorbate (vitamin C) (Boyd and Campbell, 1950, Gross, 2000, Saika et al., 1993). Other antioxidant agents such as Trolox® (a cell permeable, water soluble derivative of vitamin E) (Hallberg et al., 1996), vitamin E (Bilgihan et al., 2003) and superoxide dismutase derivatives e.g. an acylated SOD derivative (Ando et al., 1990) and lecithin bound superoxide dismutase (Shimmura et al., 2003)

Conclusion

This review demonstrates the increasing evidence of the role oxidative stress and subsequent mitochondrial dysfunction in the pathogenesis of both inherited and acquired corneal pathologies. The unique physiology of the cornea predisposes this structure to oxidative damage, and there is interplay between inherited and acquired mitochondrial dysfunction, oxidative damage and a number of corneal diseases. The imbalance of ROS and antioxidants can then result in mtDNA mutations which can play a

Acknowledgements

We kindly acknowledge the following individuals who supplied images:

Dr. Luciane Dreher Irion, Consultant Ophthalmic Histopathologist Central Manchester University Hospital (Fig. 1).

Dr. Bernhard Steger, Department Ophthalmology, Medical University of Innsbruck, Austria (Fig. 3).

References (188)

  • H. Elhalis et al.

    Fuchs endothelial corneal dystrophy

    Ocul. Surf.

    (2010)
  • X.D. Hao et al.

    Mitochondrial DNA copy number, but not haplogroup is associated with keratoconus in Han Chinese population

    Exp. Eye Res.

    (2015)
  • K. Hoffer

    Corneal decomposition after corneal endothelium cell count

    Am J. Ophthalmol.

    (1979)
  • U.V. Jurkunas et al.

    Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy

    Am. J. Pathol.

    (2010)
  • G. Lascaratos et al.

    Mitochondrial dysfunction in glaucoma: understanding genetic influences

    Mitochondrion

    (2012)
  • H.-F. Lee et al.

    The neurological evolution of Pearson syndrome: case report and literature review

    Eur. J. Paediatr. Neurol.

    (2007)
  • K.K. Abu-Amero et al.

    Mitochondrial sequence changes in keratoconus patients

    Investig. Ophthalmol. Vis. Sci.

    (2014)
  • K.K. Abu-Amero et al.

    Keratoconus is associated with increased copy number of mitochondrial DNA

    Mol. Vis.

    (2014)
  • A. Akal et al.

    Tear film and serum prolidase activity and oxidative stress in patients with keratoconus

    Cornea

    (2015)
  • M. Aktekin et al.

    Ultrastructure of the cornea epithelium in keratoconus

    Okajimas Folia Anat. Jpn.

    (1998)
  • J.L. Alio et al.

    Effect of topical antioxidant therapy on experimental infectious keratitis

    Cornea

    (1995)
  • S. Anderson et al.

    Sequence and organization of the human mitochondrial genome

    Nature

    (1981)
  • E. Ando et al.

    Inhibition of corneal inflammation by an acylated superoxide dismutase derivative

    Investig. Ophthalmol. Vis. Sci.

    (1990)
  • E. Arnal et al.

    Oxidative stress in keratoconus?

    Investig. Ophthalmol. Vis. Sci.

    (2011)
  • B.T. Ashok et al.

    The aging paradox: free radical theory of aging

    Exp. Gerontol.

    (1999)
  • L. Atalla et al.

    Immunohistochemical localization of catalase in ocular tissue

    Curr. Eye Res.

    (1987)
  • S.R. Atilano et al.

    Accumulation of mitochondrial DNA damage in keratoconus corneas

    Investig. Ophthalmol. Vis. Sci.

    (2005)
  • S.R. Atilano et al.

    Hydrogen peroxide causes mitochondrial DNA damage in corneal epithelial cells

    Cornea

    (2009)
  • M. Azevedo

    Eye Drop Treatment for Fuchs, A Mitochondria-related Disease

  • B. Azizi et al.

    p53-regulated increase in oxidative-stress-induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model

    Investig. Ophthalmol. Vis. Sci.

    (2011)
  • K.H. Baratz et al.

    E2-2 protein and Fuchs's corneal dystrophy

    N. Engl. J. Med.

    (2010)
  • G. Barja

    Free radicals and aging

    Trends Neurosci.

    (2004)
  • J. Becker et al.

    Explorative study of interleukin levels in the human cornea

    Graefes Arch. Clin. Exp. Ophthalmol.

    (1995)
  • A. Behndig et al.

    Superoxide dismutase isoenzymes in the human eye

    Investig. Ophthalmol. Vis. Sci.

    (1998)
  • A. Behndig et al.

    Superoxide dismutase isoenzymes in the normal and diseased human cornea

    Invest. Ophthalmol. Vis. Sci.

    (2001)
  • A. Bilgihan et al.

    Effects of topical vitamin E on corneal superoxide dismutase, glutathione peroxidase activities and polymorphonuclear leucocyte infiltration after photorefractive keratectomy

    Acta Ophthalmol. Scand.

    (2003)
  • J.A. Bonanno

    Identity and regulation of ion transport mechanisms in the corneal endothelium

    Prog. Retin. Eye Res.

    (2003)
  • F. Boonstra et al.

    Corneal decompensation in a boy with Kearns-Sayre syndrome

    Ophthalmic Genet.

    (2002)
  • W.M. Bourne

    Biology of the corneal endothelium in health and disease

    Eye (Lond).

    (2003)
  • W.M. Bourne et al.

    Central corneal endothelial cell changes over a ten-year period

    Investig. Ophthalmol. Vis. Sci.

    (1997)
  • T. Boyd et al.

    Ascorbic Acid and Healing of Corneal Ulcers

    (1950)
  • A.M.V. Brooks et al.

    Fluorescein angiography of the iris and specular microscopy of the corneal endothelium in some cases of glaucoma secondary to chronic cyclitis

    Ophthalmology

    (2016)
  • M. Brown et al.

    Molecular basis of mitchondrial DNA disease

    J. Bioenerg. Biomembr.

    (1994)
  • D. Brown et al.

    Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors

    Curr. Eye Res.

    (1993)
  • D.J. Brown et al.

    Elements of the nitric oxide pathway can degrade TIMP-1 and increase gelatinase activity

    Mol. Vis.

    (2004)
  • R.F. Brubaker et al.

    Ascorbic acid content of human corneal epithelium

    Invest. Ophthalmol. Vis. Sci.

    (2000)
  • R. Buddi et al.

    Evidence of oxidative stress in human corneal diseases

    J. Histochem. Cytochem.

    (2002)
  • J. Čejková et al.

    Xanthine oxidoreductase and xanthine oxidase in human cornea

    Histol. Histopathol.

    (2002)
  • T.S. Chang et al.

    Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes

    Arch. Ophthalmol.

    (1993)
  • T.S. Chang et al.

    Corneal decompensation in mitochondrial ophthalmoplegia plus (Kearns-Sayre) syndrome: a clinicopathologic case report

    Cornea

    (1994)
  • Cited by (72)

    View all citing articles on Scopus

    This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

    View full text